These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8077766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiviral and antiproliferative activities of human leukocyte interferon potentiated by cimetidine in vitro.
    Hirai N, Hill NO, Motoo Y, Osther K.
    J Interferon Res; 1985; 5(3):375-82. PubMed ID: 2997335
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
    Hu CJ, Ozes ON, Klein SB, Blatt LM, Taylor MW.
    J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M, Belkowski LS, Bloom BR.
    J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiviral and antiproliferative activities of three molecular components of leukocyte-derived human interferon.
    Dinolfo E, Chadha KC.
    Microbiol Immunol; 1983 Sep; 27(7):589-99. PubMed ID: 6314101
    [Abstract] [Full Text] [Related]

  • 12. Human interferon and cell growth inhibition. VII. Reversibility of interferon activities.
    Dahl H.
    J Interferon Res; 1983 Sep; 3(4):387-93. PubMed ID: 6323590
    [Abstract] [Full Text] [Related]

  • 13. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON, Reiter Z, Klein S, Blatt LM, Taylor MW.
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
    Overall JC, Yeh TJ, Kern ER.
    J Interferon Res; 1984 Feb; 4(4):529-33. PubMed ID: 6094683
    [Abstract] [Full Text] [Related]

  • 16. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA, Lingwood CA.
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
    Zhang XT, Samuel CE.
    J Biol Regul Homeost Agents; 1987 Jan; 1(4):157-65. PubMed ID: 2845723
    [Abstract] [Full Text] [Related]

  • 18. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M.
    Arch Immunol Ther Exp (Warsz); 1987 Jan; 35(4):489-99. PubMed ID: 2449874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.